MIRA Pharmaceuticals, Inc.
MIRA
$1.41
-$0.01-0.70%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 13.80% | 25.67% | -17.41% | -20.85% | 1.54% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -44.03% | 59.99% | 103.27% | -55.52% | 20.91% |
| Change in Net Operating Assets | 134.46% | -1,605.43% | 171.17% | -130.23% | 32.50% |
| Cash from Operations | 50.94% | 9.70% | 2.01% | -113.23% | 17.68% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 200.00% | -159.67% | 200.00% |
| Issuance of Common Stock | -- | -99.29% | -84.70% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -100.00% | -64.59% | -- |
| Cash from Financing | 9,423.53% | -99.31% | -84.40% | 1,889.25% | 754.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 70.75% | -24.02% | -199.30% | 287.37% | 34.36% |